ABNORMALITIES in iron metabolism characterized by an increase in marrow reticuloendothelial iron, low plasma iron and transferrin concentration with a corresponding reduction in transferrin saturation are a common feature of generalized Hodgkin's disease. Iron kinetic studies using 59Fe labelled transferrin have shown that a diminished turnover time is also a common feature and that the plasma iron turnover may be reduced, normal or increased (Giannopoulos and Bergsagel, 1959; Cline and Berlin, 1963) . When 59Fe haemoglobin is injected intravenously it is rapidly cleared by the reticuloendothelial (RE) system and studies of radioactive iron utilization following its administration have shown diminished red cell incorporation in patients with generalized Hodgkin's disease (Haurani, Young and Tocantins, 1963) . This is thought to be due to a failure of RE cells to release iron derived from the catabolism of haemoglobin, and this state is associated with a low plasma iron concentration and consequent impaired delivery to the bone marrow (Cartwright and Lee, 1971 ). An alternative method of measuring RE cell iron release involves a double isotope technique in which 55Fe labelled iron dextran replaces labelled haemoglobin and 59Fe labelled transferrin is used to measure plasma iron utilization (Beamish et al., 1971) . Defective RE release of iron in Hodgkin's disease has also been demonstrated by this technique, which has the advantage of eliminating the difficulties associated with intravenous infusion of labelled haemoglobin solutions.
Previous studies carried out to define the abnormalities of iron metabolism in Hodgkin's disease have been performed on small numbers of selected patients, usually with advanced generalized disease and often following treatment with radiotherapy or chemotherapy. The present day use of lymphangiography, tomography, and diagnostic laparotomy has allowed the clinician to stage the disease with increasing accuracy. The present study was undertaken to define more precisely the abnormalities in iron metabolism in untreated cases and to relate these changes to the extent of the disease at the time of diagnosis as judged by the clinical stage.
PATIENTS AND METHODS
A total of 29 new patients (22 male and 7 female) were studied. A lymph node biopsy was taken in each case and on this basis 23 patients were diagnosed as Hodgkin's disease and 6 patients as either lymphosarcoma (3), reticulum cell sarcoma (2) or Brill-Symmers disease (1). Each patient with Hodgkin's disease was classified into Stages 1, 2, 3 or 4 with the aid of mediastinal tomography, abdorniinal lymphangiography, liver and spleen scanniing using technicium 99 m and placed into Groups A or B according to the absence or presence of generalized symptoms of fever, pruritus or night sweats (Rosenberg, 1966) . For the purpose of the study the patients were divided into a Hodgkin's disease group and a non-Hodgkin's lymphoma group. Besides classification into stages, the Hodgkin's disease group was also arbitrarily divided into a localized group (Stages IA or 2A) and a generalized group (Stages iB, 2B, 3 or 4). Haemoglobin (Hb) concentration, haematocrit, mean corpuscular volume (MCV), mean corpuscular haemoglobin concentration (MCHC) and direct antiglobulin tests were performed by standard methods (Dacie and Lewis, 1968) . Serum iron (SI) and total iron-biniding capacity (TIBC) were measured by the method of Young and Hicks (1965) using magnesium carbonate as absorbent. A sternal marrow aspirate was obtained from each patient and the stainable iron graded from 0 to 6 according to Rath and Finch (1948) . One iron deficient patient with absent stainable iron was excluded from the study. Stainable reticuloendothelial iron appeared to be present in larger amounts in patients with Stage 3 and 4 disease than in those with Stages 1 and 2. Radio-isotope studies.-Radioiron studies were performed on each patient and on 12 healthy volunteers whose consent had been obtained. The 59Fe labelled transferrin was prepared in vitro from the subject's own plasma by the method of Cavill (1971) . The 55Fe labelled iron dextran was prepared by The°,/ transferrin iron utilization 14 days after injection of 59Fe transferrin was calculated from the formula: iron utilization =red-cell volume (ml)
x 59Fe activity/ml red cells x 100 Total 59Fe activity injected The red-cell volume wvas directly estimated from in vivo dilution of 5'Cr labelled red cells (Dacie and Lewis, 1968) in cases which had been labelled with 5'Cr and from the tables of Nadler, Hidalgo and Bloch (1962) The erythrocyte iron turnover (EIT) was calculated from the formula: EIT (mg iron/100 ml blood/24 hours) = transferrin iron utilization x PIT The red cell survival was expressed as red cell 51Cr T' in days anid calculated from the regression of log whole blood activity against time.
RESULTS

Haemoglobin concentration
The mean haemoglobin concentration in the entire Hodgkin's disease group was 13*5 g/100 ml and in the iion-Hodgkin's group 13 6 g/100 ml (Table I ). Both are significantly less than the normal controls (P < 0 01 and <0 05 respectively). Patients with Stage I disease have nornmal concentrations (Fig. 1) and significantly decreased concentrations are found with more widespread disease and in the patients with symptomns of generalized involvement.
Serum iron and transferrin saturation
The mean values are shown in Table I and the individual results for serum iron concentrations in Fig. 2 . They are significantly reduced in both the Hodgkin's disease and non-Hodgkin's lymphoma groups (P < 0 001). The decrease in the serum iron level is related to the clinical staging of the disease at diagnosis. There is a significant reduction in Stage I disease compared with normal (P < 0.025) although only one result is outside the normal range. The mean serum iron level in the localized group differs significantly from that in the generalized group (86.7 + 8&2 g/100 ml and 48-7 ± 4-6 g/100 ml respectivelv; P < 0.001) though there is some overlap in the individual values (Fig. 2) . The mean 00 transferrin odgkins Disease Table I ). The turnover time of all but one case is diminished in Stages 3 and 4, there being no overlap with Stage 1 (Fig. 3) . The turnover times in Stage 2 are either normal or decreased and it is notable that they are significantly decreased in those patients in Stage 2 who relapsed within 4 months of radiotherapy, possibly indicating incorrect staging at the time of diagnosis (Fig. 3) Reticuloendothelial iron release The mean value for each group is shown in Table I . Only 2 of the 15 cases of Hodgkin's disease studied fell within the normal range. It is significant that the RE iron release was low in the 3 out of 4 Stage I cases in which it was measured (Fig. 4) . There is no significant difference between the mean values of the localized (44.6 ± 9.6%) and the generalized group (39.2 i 5.4oo). The RE iron release was normal in the 2 non-Hodgkin's lymphoma group cases in which it was estimated.
Red cell survival
Red cell survival is progressively reduced with each stage in the advance of the disease (Table I ). The 51Cr half time is 28-8 days in Stage 1 and 21-0 days in Stage 4. The mean value for patients in the localized group is 27-7 ± 0-96 days and 23-9 i 1-96 days for those in the generalized group. The 2 patients with values of below 22 days had generalized Hodgkin's disease. The red cell survival showed a significant negative correlation with the PIT (r =-0.7, P < 0.005).
DISCUSSION
A haemoglobin concentration less than 12-0 g/100 ml was found in 5 of the 29 patients. The mean haemoglobin concentration in patients with localized disease (Stages IA and 2A) was not significantly different from that of normal subjects but there was a significantly lower haemoglobin concentration in those with generalized disease. The incidence of anaemia is comparable to that found by Levinson et al. (1957) (Hoffbrand, 1964) . The extent to which haemolysis contributes to anaemia is difficult to assess. There is no significant correlation between haemoglobin concentration and 51Cr T' in the present series. There is, however, a significant negative correlation between the 51Cr T' and the PIT, suggesting that the previously reported high PIT in Hodgkin's disease (Giannopoulos and Bergsagel, 1959 ) is consequent upon the increased erythroid proliferation in the marrow compensating for haemolysis.
Ineffective erythropoiesis with impaired incorporation of iron into circulating erythrocytes has been reported by Cline and Berlin (1963) . They studied 8 patients and found substantially reduced erythrocyte iron turnover, with normal or elevated plasma iron turnover, in 3 patients with disease. Other workers have reported normal or increased transferrin iron utilization (Haurani et al., 1963; Najean et al., 1967) . In the present study, transferrin iron utilization was not significantly different from normal, nor were abnormal values found in any sub-group, indicating that neither depressed nor ineffective erythropoiesis is a significant feature of the disease.
An impaired ability of the RE cell to release iron is a feature of chronic disease (Cartwright and Lee, 1971) . The consequent defect in reutilization of haemoglobin iron is characterized by a low serum iron concentration, a low or normal total iron binding capacity, decreased plasma iron turnover time and increased reticuloendothelial iron stores. This defect has been directly measured in dogs with turpentine abscesses following the transfusion of radioiron labelled non-viable red cells (Freireich et al., 1957) . Haurani et al. (1963) used 59Fe labelled haemoglobin solution prepared by incubating 90 ml of blood with an increased reticulocyte count with 59Fe ferrous citrate, which was then given to patients by intravenous infuision.
The present study has made use of 55Fe iron dextran as an alternative to haemoglobin or red cells to study RE cell iron release as it has the advantages of being a stable compound, convenient for clinical use, with none of the disadvantages and dangers associated with the transfusion of relatively large quantities of haemoglobin solution or senescent red cells. Iron dextran is rapidly cleared from the circulation into RE cells and the iron released behaves in a similar manner to that released from haemoglobin (Henderson and Hillman, 1969) . Previous studies have established this method as a valid procedure for the estimation of RE iron release (Beamish et al., 1971) .
A defect of RE iron release in generalized Hodgkin's disease has been demonstrated in earlier work. Haurani et al. (1963) In the present study, transferrin saturation was below 15%o in 9 out of 29 patients, of whom 8 had generalized disease. The mean PIT values in these cases is significantly lower than in those with a saturation of above 15%, indicating a diminished delivery of iron to the erythroid marrow with resulting iron deficient erythropoiesis. The results indicate the absence of any intrinsic defect in erythropoiesis as judged by normal utilization of transferrin bound radioiron. The most consistent finding, a failure of the RE cell to release iron, is seen in both localized and generalized disease, reflecting a generalized abnormality of the RE system which appears early in the evolution of the disease. This abnormality is also associated with an increase in red cell destruction in some cases. The two phenomena give a reduction in haemoglobin concentration due to a haemolytic state only partially compensated because of iron deficiency erythropoiesis.
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